ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinkovics, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinkovics, J.
Annals of Clinical and Laboratory Science, Vol 16, Issue 6, 488-496
Copyright © 1986 by Association of Clinical Scientists


Articles

Cytotoxic lymphocytes

JG Sinkovics

Interactions between human lymphocytes and target cells are highly variable. Lymphocytes may enter fibroblasts, establish cytoplasmic bridges, and draw material through these bridges from the fibroblasts; these lymphocytes may undergo divisions within the fibroblasts, while the fibroblasts vacuolize and die. In this interaction, the fibroblasts may serve as feeder cells to the lymphocytes without any immunological principle involved. Small (presumably immune T) and large (presumably NK) lymphocytes of tumor-bearing patients lyse either autologous, or allogenic, or both autologous and allogeneic tumor cells. Serum factors can block or intensify these reactions. Healthy donors frequently yield lymphocytes cytotoxic to tumor cells. Serum factors blocking the cytotoxicity of patients' lymphocytes frequently fail to block the cytotoxicity of healthy donors' lymphocytes.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the Association of Clinical Scientists.